8-K: Ambac Financial Group Reports Strong P&C Growth in Q4 and Full Year 2024, Strategic Transition Nears Completion

Ambac Financial Group's Q4 2024 results highlight significant growth in its Specialty P&C Insurance business and progress in its strategic transition, despite a net loss due to discontinued operations accounting.

Summary

• Ambac Financial Group reported its Q4 2024 and full-year results, showcasing a strategic shift towards its Specialty P&C Insurance business.
• The company is in the final stages of selling its Legacy Financial Guarantee business to funds managed by Oaktree Capital Partners for $420 million.
• This sale led to a $(570) million loss on disposal in Q4, resulting in a consolidated net loss to Ambac common stockholders of $(548) million, or $(10.23) per diluted share.
• Total revenue from continuing operations increased by 89% for the year, reaching $236 million.
• Specialty P&C Insurance premium increased by 74% for the year, totaling $876 million.
• Insurance Distribution (Cirrata) revenue grew by 257% in Q4 to $44 million and 93% for the year to $99 million.
• Adjusted EBITDA to Ambac common stockholders was $5 million for the quarter, up 270%, and $13 million for the year, up 43%.
• The combined ratio for Specialty P&C Insurance (Everspan) improved by 380 bps over Q4 2023 to 96.5%.
• During Q4 2024, Ambac repurchased 962,141 shares at an average price of $12.48 per share, and an additional 239,791 shares in Q1 2025 at an average price of $11.71 per share.
• As of December 31, 2024, stockholders' equity was $857 million, or $18.43 per share.

Sentiment

Score: 6

Explanation: The sentiment is mixed. While there's strong growth in the P&C and distribution businesses, the significant net loss due to discontinued operations and the ongoing regulatory approval process for the Legacy business sale temper the overall outlook.

Positives

• Significant growth in Specialty P&C Insurance premium, increasing 74% for the year.
• Strong revenue growth in Insurance Distribution (Cirrata), with a 257% increase in Q4.
• Improved combined ratio for Specialty P&C Insurance (Everspan), reaching 96.5% in Q4.
• Adjusted EBITDA to Ambac common stockholders increased significantly, up 270% in Q4.
• Successful launch of 6 new MGAs, exceeding expectations.
• Share repurchase program executed, indicating management's confidence in the company's value.

Negatives

• A significant net loss of $(548) million to Ambac common stockholders, primarily due to the loss on disposal of the Legacy Financial Guarantee business.
• Net loss from continuing operations to Ambac common stockholders of $(6) million and $(7) million for the quarter and year, respectively.
• Gross premium written and net premium written both contracted during the fourth quarter of 2024 relative to the fourth quarter of 2023 due to Everspan's cancellation of a personal lines non-standard auto reinsurance program in the fourth quarter of 2024.
• Corporate loss of $(18) million and $(63) million for the fourth quarter and full year 2024.

Risks

• The sale of the Legacy Financial Guarantee business is still subject to Wisconsin regulatory approval.
• The company's future performance is subject to various risks, including credit risk, underwriting losses, and the inability to obtain reinsurance coverage on expected terms.
• The company's substantial indebtedness could adversely affect its financial condition and operating flexibility.
• Failure to realize expected benefits from investments in technology.
• The high degree of volatility in the price of AFGs common stock.

Future Outlook

Ambac anticipates closing the sale of its Legacy Financial Guarantee business by early second quarter 2025, pending Wisconsin regulatory approval, and expects a strong pipeline for organic and strategic growth in 2025.

Management Comments

• Claude LeBlanc, President and Chief Executive Officer, stated, 'Our P&C operating businesses had record performances in 2024, generating nearly $900 million in premiums across the platform.'
• LeBlanc also mentioned that Cirrata earned nearly $20 million of Adjusted EBITDA, up from $11 million the prior year, and Everspan contributed another $5 million, an increase of 400% over last year.
• LeBlanc continued, 'Looking at 2025 our pipeline for organic and strategic growth remains very strong.'

Industry Context

Ambac's strategic shift towards Specialty P&C Insurance and Insurance Distribution aligns with the industry trend of focusing on specialized underwriting and distribution capabilities. The growth in these segments positions Ambac to capitalize on increasing demand for niche insurance products and services.

Comparison to Industry Standards

• A combined ratio of 96.5% for Everspan is competitive within the specialty P&C insurance sector, where the industry average typically aims to be below 100%.
• Companies like RLI Corp. and W. R. Berkley Corp. are known for their strong underwriting performance and consistently achieve combined ratios in the low-90s.
• The growth rate of 74% in Specialty P&C Insurance premium is significant compared to the overall P&C insurance market, which typically grows at a slower pace.
• Insurance distribution companies like Brown & Brown and Acrisure have also been experiencing growth through acquisitions and organic expansion, similar to Ambac's strategy with Cirrata and Beat Capital.

Stakeholder Impact

• Shareholders will be impacted by the net loss, but may benefit from the company's strategic shift and growth in core businesses.
• Employees in the Specialty P&C Insurance and Insurance Distribution segments may experience growth opportunities.
• Customers may benefit from the company's focus on specialized insurance products and services.

Next Steps

• Complete the sale of the Legacy Financial Guarantee business, pending Wisconsin regulatory approval.
• Continue to focus on organic and strategic growth in the Specialty P&C Insurance and Insurance Distribution segments.
• Execute the remaining share repurchase authorization.
• Monitor and manage risks associated with the company's indebtedness and market conditions.

Key Dates